11-55638757-A-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001004124.2(OR4P4):āc.400A>Gā(p.Met134Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,492,658 control chromosomes in the GnomAD database, including 482 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001004124.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4P4 | NM_001004124.2 | c.400A>G | p.Met134Val | missense_variant | 1/1 | NP_001004124.1 | ||
OR4P4 | NM_001405919.1 | c.400A>G | p.Met134Val | missense_variant | 2/2 | NP_001392848.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4P4 | ENST00000641760.1 | c.400A>G | p.Met134Val | missense_variant | 2/2 | ENSP00000493384.1 |
Frequencies
GnomAD3 genomes AF: 0.000893 AC: 124AN: 138878Hom.: 22 Cov.: 26
GnomAD3 exomes AF: 0.000773 AC: 175AN: 226246Hom.: 31 AF XY: 0.000873 AC XY: 107AN XY: 122594
GnomAD4 exome AF: 0.00169 AC: 2288AN: 1353692Hom.: 460 Cov.: 31 AF XY: 0.00161 AC XY: 1083AN XY: 673284
GnomAD4 genome AF: 0.000892 AC: 124AN: 138966Hom.: 22 Cov.: 26 AF XY: 0.000874 AC XY: 59AN XY: 67520
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.400A>G (p.M134V) alteration is located in exon 1 (coding exon 1) of the OR4P4 gene. This alteration results from a A to G substitution at nucleotide position 400, causing the methionine (M) at amino acid position 134 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | OR4P4: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at